Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2025-12-31 @ 9:00 AM
Study NCT ID:
NCT05045404
Status:
WITHDRAWN
Last Update Posted:
2023-09-13
First Post:
2021-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-07
First Submit QC Date:
None
Study First Post Date:
2021-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-11
Last Update Post Date:
2023-09-13
Last Update Post Date Type:
ACTUAL